ReviewMetabolism open2026
GLP-1 receptor agonists and obstructive lung disease: Beyond metabolic control to respiratory outcomes.
Vasiliki Epameinondas Georgakopoulou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it